Non-interventional PASS to Evaluate Safety of Kineret in Treatment of CAPS in Routine Clinical Care With Regard to Serious Infections, Malignancies, Injection Site Reactions, Allergic Reactions, Medication Errors Including Re-use of Syringe
Phase of Trial: Phase IV
Latest Information Update: 29 Aug 2016
At a glance
- Drugs Anakinra (Primary)
- Indications Cryopyrin-associated periodic syndromes
- Focus Adverse reactions
- Sponsors Swedish Orphan Biovitrum
- 19 Aug 2016 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 19 Aug 2016 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.
- 03 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.